LS Securities Lowers Hanssem Target Price, Adjusts Profit Estimates

Reporter Kim SangJin / approved : 2024-08-14 03:10:02
  • -
  • +
  • 인쇄

(Photo= Yonhap news)

 

[Alpha Biz= Reporter Kim Sangjin] LS Securities has adjusted its target price for Hanssem downward following the company’s second-quarter earnings shock. The revised target price reflects a significant reduction in profit estimates due to disappointing financial results.

Hanssem reported second-quarter revenue of 478 billion won and operating income of 7.1 billion won, falling short of market consensus by 5.7% and 50.5%, respectively. The shortfall was primarily attributed to a 4.6 billion won loss related to Tiemef (Tmon·Wemaef) and a decline in B2B sales due to a sluggish housing market since 2021.

LS Securities analyst Kim Se-ryeon noted that the company’s performance was impacted by the Tiemef-related losses and the weak B2B market, which led to lower-than-expected revenue and earnings. The third quarter is anticipated to be a seasonal low, with additional costs of up to 2.5 billion won related to Tiemef risks potentially affecting results.

Despite these challenges, Kim highlighted that Hanssem’s top-line growth will be crucial, particularly if macroeconomic conditions improve with potential interest rate cuts. The structural increase in market share remains a key factor supporting Hanssem’s high valuation.

LS Securities has maintained its "Buy" rating but reduced the target price from 74,000 won to 70,000 won, reflecting a 5.4% decrease.

 

 

Alphabiz Reporter Kim SangJin(letyou@alphabiz.co.kr)

어플

주요기사

Bomb Threats Target Major Korean Companies Including Samsung Electronics2025.12.19
FSS Raises Consumer Alert to “Warning” Over Secondary Scams Linked to Coupang Data Breach2025.12.19
Final U.S. Defense Authorization Bill Omits Provisions Supporting South Korea-Japan Shipbuilding Cooperation2025.12.19
Controversy Surrounds KT’s Former Outside Director Cho Seung-ah Amid Dual Directorship Issue2025.12.19
Samsung Securities Lowers LG Energy Solution Target Price to KRW 480,000 Amid Contract Cancellations2025.12.19
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사